Dihexa
Research profile · How we handle evidence
Dihexa is a synthetic peptide that has been discussed in preclinical literature and in research/bioregulator communities for its synaptogenic (synapse-related) activity.
Evidence Score
Preclinical signal
Category
Therapeutic area
Standard Dose
Once daily
Half-life
Plasma elimination
Route
Oral or Subcutaneous
Safety Tier
Limited data
Overview
Dihexa is sometimes described as a very strong ‘synaptogenic’ compound in preclinical assay language. That reputation comes from laboratory work, not from broad, validated clinical outcomes. Also, parts of the Dihexa evidence story have had quality and reliability concerns in the scientific record, so it’s worth treating it cautiously and checking primary sources. For this catalog, the aim is educational: understand the claims, the assay context, and the uncertainty. If you’re considering any neuroactive research chemical, prioritize risk awareness, avoid making medical assumptions, and stop if you feel unwell.
Mechanism of Action
Dihexa is sometimes described as a very strong ‘synaptogenic’ compound in preclinical assay language. That reputation comes from laboratory work, not from broad, validated clinical outcomes. Also, parts of the Dihexa evidence story have had quality and reliability concerns in the scientific record, so it’s worth treating it cautiously and checking primary sources. For this catalog, the aim is educational: understand the claims, the assay context, and the uncertainty. If you’re considering any neuroactive research chemical, prioritize risk awareness, avoid making medical assumptions, and stop if you feel unwell.
Benefits
- Synapse-related (synaptogenic) activity discussed in preclinical research
Side Effects
- Limited human safety data
- Unknown long-term risk profile; treat as investigational
Contraindications
- Pregnant or breastfeeding women
- Individuals under 18 years old
- Those with known allergies to peptide components
Structure & Sequence
Verified structure
Dihexa
Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.
- Amino Acid Sequence
- N-hexanoic-Tyr-Ile-Ahx-NH2 (Ahx=6-aminohexanoic acid)
- Molecular Weight
- 504.66 Da
- Chemical Formula
- C27H44N4O5
- CAS Number
- N/A
Stack & Route Context
Stacks with
- Noopept
- Modafinil
Administration
Oral or Subcutaneous
Research Status
Preclinical research context; evaluate evidence quality and availability of reliable human data.
Approval Status
Preclinical
Sports Legal
Permitted
References
- 1View source
Dihexa evidence status / overview (context for reliability and interpretation)
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.